MSOS's metric understates risk by excluding large tax liabilities, especially for CURLF and TCNNF. Learn more about the MSOS ...

Cannabis stocks often trade less on traditional fundamentals alone and more on changes in policy. Cannabis ETFs are a narrow ...

These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last ...

Cannabis ETFs entered 2026 after multiple fund closures, stalled federal reform, and a prolonged multi‑year drawdown in ...

New cannabis rules boost medical-only profits while challenging multi-state operators.

Cannabis multi-state operators, which surged Wednesday following a report that marijuana would be reclassified as a Schedule ...

AdvisorShares Pure US Cannabis ETF (MSOS) dropped 26% to $4.80 by mid-January despite Trump’s December executive order. MSOS holds $921M and gains exposure to Curaleaf and Trulieve through swap ...

Investors in Advisorshares Trust Advisorshares Pure US Cannabis (Symbol: MSOS) saw new options begin trading today, for the February 25th expiration. At Stock Options Channel, our YieldBoost formula ...

Will the rescheduling of cannabis fuel a boom in cannabis stocks? Analysts from Z&A delve into the pros and cons of MSOs and cannabis rescheduling in their latest equity research report. Re-scheduling ...

Sun, January 18, 2026 at 3:59 PM UTC The AdvisorShares Pure US Cannabis ETF has spent the last month on a rollercoaster. After climbing to $6.45 in mid-December 2025, shares dropped 26% to around ...